MRVI Competitors & Alternatives
Compare Maravai Lifesciences Holdings Inc with similar stocks in the same industry
Biotechnology
MRVI
Main Stock$7.86
Tradestie Score
50
Market Cap
$454.29M
Revenue Growth
0.1%
Analyst Upside
+19.8%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.55
|
$2.23B | - | 54 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$29.36
|
$2.22B | - | 45 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$51.99
|
$2.21B | - | 66 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$19.85
|
$2.18B | - | 37 | Compare |
|
CERT
Certara, Inc. Common Stock
|
$12.13
|
$2.15B | - | 34 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$13.99
|
$2.08B | - | 34 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$16.42
|
$2.02B | 862.0 | 33 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$11.17
|
$2.01B | - | 46 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$31.64
|
$1.97B | - | 41 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$6.61
|
$1.92B | - | 65 | Compare |
More MRVI Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry